CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+1.24%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$2.46B
AUM Growth
+$2.46B
(-4%)
Cap. Flow
+$92.2M
Cap. Flow
% of AUM
3.75%
Top 10 Holdings %
Top 10 Hldgs %
47.28%
Holding
111
New
8
Increased
8
Reduced
35
Closed
20
Top Buys
| 1 |
Erasca
ERAS
|
$217M |
| 2 |
Immuneering
IMRX
|
$58.5M |
| 3 |
Tango Therapeutics
TNGX
|
$38.8M |
| 4 |
Cytokinetics
CYTK
|
$35.7M |
| 5 |
Tyra Biosciences
TYRA
|
$18.2M |
Top Sells
| 1 |
Atea Pharmaceuticals
AVIR
|
$52M |
| 2 |
Twist Bioscience
TWST
|
$24.7M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$22M |
| 4 |
908 Devices
MASS
|
$21.1M |
| 5 |
C4 Therapeutics
CCCC
|
$13.4M |
Sector Composition
| 1 | Healthcare | 99.61% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
C4 Therapeutics
CCCC
$182M
| – | – |
-354,495
| Closed | -$13.4M |
|
102
ARK Innovation ETF
ARKK
$7.43B
| – | – |
0
| – | – |
|
103
ARK Genomic Revolution ETF
ARKG
$1.05B
| – | – |
0
| – | – |
|
|
HGEN
104
DELISTED
HUMANIGEN, INC.
HGEN
| – | – |
-600,000
| Closed | -$10.4M |
|
|
EIGR
105
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| – | – |
-284,988
| Closed | -$2.43M |
|
106
Zai Lab
ZLAB
$3.48B
| – | – |
-53,455
| Closed | -$9.46M |
|
|
107
Twist Bioscience
TWST
$1.57B
| – | – |
-185,000
| Closed | -$24.7M |
|
108
Theravance Biopharma
TBPH
$691M
| – | – |
-300,000
| Closed | -$4.36M |
|
|
SWTX
109
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-15,000
| Closed | -$1.24M |
|
110
ARS Pharmaceuticals
SPRY
$1.08B
| – | – |
-239,099
| Closed | -$7.39M |
|
111
Repare Therapeutics
RPTX
$73.9M
| – | – |
-363,766
| Closed | -$11.3M |
|